Journals / Androloji Bülteni / 2023 / Cilt: 25 - Sayı: 2

Managing priapism in childhood

Çocuklarda priapizme yaklaşım

Pages
119–126
Publication Date
2023-11-27
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the literature is searched in order to understand and manage properly the clinical classification, etiology, pathology and novel treatment modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Priapism is defined as a persistent erection that prolongs for more than 4 to 6 hours regardless of sexual stimulation.
📊
Key Findings & Data:It is rare in pediatdrc population and might be frequently due to sickle cell anemia, hematologic disorders, toxins, malignancy and drugs.
💡
Conclusion & Impact:In this review, the literature is searched in order to understand and manage properly the clinical classification, etiology, pathology and novel treatment modalities.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Priapism is defined as a persistent erection that prolongs for more than 4 to 6 hours regardless of sexual stimulation. It is rare in pediatdrc population and might be frequently due to sickle cell anemia, hematologic disorders, toxins, malignancy and drugs. Ischemic subtype is the most common type in childhood. It is still challenging for clinicians to manage pediatric age patients with priapism in consequence of lack of well established data. In this review, the literature is searched in order to understand and manage properly the clinical classification, etiology, pathology and novel treatment modalities.

Özet

Priapizm tanım olarak cinsel istek ve uyarıdan bağımsız yaklaşık 4–6 saat süren uzamış ereksiyon halidir. Pediatrik popülasyonda nadir görül- mekle birlikte altta yatan etiyolojik faktör genellikle orak hücre anemisi olup, hiperkoagülopati, ilaçlar, malignite, toksinler ve idiopatik faktör - lerde altta yatan sebep olabilmektedir. İskemik düşük akımlı priapizm çocuklarda görülen en sık priapizm tipidir. Çocukluk çağında priapizmi yönetmek, kanıta dayalı verilerin olmaması nedeniyle halen klinisyenleri zorlamaktadır. Bu derlemede pediatrik popülasyonda priapizm hakkın- da klinik sınıflandırma, etiyoloji, patofizyolojisi ve güncel tedavileri göz- den geçirilerek sunulmaktadır.

🔖

Cite This Article

AKKAŞ, B., CAYLAN, A. E., UÇAR, M. (2023). Managing priapism in childhood. Androloji Bülteni, Cilt: 25 - Sayı: 2, 119–126. https://doi.org/10.24898/tandro.2023.67984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Tripe J. Clinical contributions from private practice: case of continued priapism. Lancet. 1845
  2. 8–9. [CrossRef] 2. Donaldson JF, Rees RW, Steinbrecher HA. Priapism in children: a comprehensive review and clinical guideline. J Pediatr Urol. 2014
  3. 11–24. [CrossRef] 3. Broderick GA. Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy. J Sex Med. 2012
  4. 88–103. [CrossRef] 4. Montorsi F, et al. Sexual medicine: sexual dysfunction in men and woman. Proceedings of the 3rd International Consultation on Sexual Medicine. Paris
  5. Emond AM, Holman R, Hayes RJ, Serjeant GR. Priapism and impotence in homozygous sickle cell disease. Arch Intern Med. 1980
  6. 1434–7. [CrossRef] 6. Chow K, Payne S. The pharmacological management of intermittent priapismic states. BJU Int. 2008
  7. 1515–21. [CrossRef] 7. Aktoz, T, Tepeler A, Gündoğdu EO, Ozkuvanci U, Müslümanoğlu AY. Priapism in the newborn: management and review of literature. Andrologia. 2011
  8. 65–7. [CrossRef] 8. Dust N, Daboval T, Guerra L. Evaluation and management of priapism in a newborn: a case report and review of the literature. Paediatr Child Health. 2011
  9. e6–8. [CrossRef] 9. Eland I, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology. 2001
  10. 970–2. [CrossRef] 10. Kulmala RV, Lehtonen TA, Tammela TL. Priapism, its incidence and seasonal distribution in Finland. Scand J Urol Nephrol. 1995
  11. 93–6. [CrossRef] 11. Adeyoju A, Olujohungbe ABK, Morris J, Yardumian A, Bareford D, Akenova A, et al. Priapism in sickle cell disease: incidence, risk factors and complications -an international multicentre study. BJU Int. 2002
  12. 898–902. [CrossRef] 12. Mantadakis E, Ewalt DH, Don Cavender J, Rogers ZR, Buchanan GR. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood. 2000
  13. 78–82. [CrossRef] 13. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010
  14. 476–500. [CrossRef] 14. de Jesus LE, Dekermacher S. Priapism in children: review of pathophysiology and treatment. J Pediatr (Rio J). 2009
  15. 194– 200. [CrossRef] 15. Castagnetti M, Larsen EL, Devidas M, Linda SB, Blach L, Carroll AJ, et al. Conservative management of priapism secondary to leukemia. Pediatr Blood Cancer. 2008
  16. 420–3. [CrossRef] 16. Shih WV, Wong C. Priapism and hemodialysis: case report and literature review. Clin